/wp-content/uploads/peel_logo.svg
0
0
Trent Fowler
/wp-content/uploads/peel_logo.svg
Trent Fowler2023-11-01 11:00:272023-11-02 14:16:17Peel Therapeutics to Present Data on its TOP1 Inhibitor PEEL-224 at the Connective Tissue Oncology Society Annual Meeting and Society for Immunotherapy of Cancer Annual Meeting
/wp-content/uploads/peel_logo.svg
0
0
Trent Fowler
/wp-content/uploads/peel_logo.svg
Trent Fowler2023-04-13 08:30:582023-04-13 06:52:59Peel Therapeutics Reports Excessive NETosis Induction in Long COVID
/wp-content/uploads/peel_logo.svg
0
0
Trent Fowler
/wp-content/uploads/peel_logo.svg
Trent Fowler2023-02-23 07:00:162023-02-23 06:44:23Peel Therapeutics Closes New Financing Round and Expands Board of Directors to Support Evolution-Based Medicines for Cancer and Inflammation
/wp-content/uploads/peel_logo.svg
0
0
David Anderson
/wp-content/uploads/peel_logo.svg
David Anderson2022-08-10 00:00:002022-08-10 05:05:30PEEL Therapeutics Initiates Clinical Trial of PEEL-224 in Patients with Advanced Solid Tumors
/wp-content/uploads/peel_logo.svg
0
0
David Anderson
/wp-content/uploads/peel_logo.svg
David Anderson2020-08-24 08:00:002022-07-22 12:54:35PEEL Therapeutics Developing Cancer Drug from Plant Toxin
/wp-content/uploads/peel_logo.svg
0
0
David Anderson
/wp-content/uploads/peel_logo.svg
David Anderson2020-06-29 00:14:142022-07-22 12:56:32PEEL Therapeutics Announces Possible New Treatment for COVID-19
Scroll to top
